Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 3
1954 1
1958 1
1959 1
1961 4
1962 10
1963 1
1964 1
1965 1
1966 2
1968 1
1969 4
1970 2
1971 6
1972 9
1973 5
1974 7
1975 6
1976 11
1977 4
1978 8
1979 9
1980 6
1981 23
1982 13
1983 18
1984 18
1985 22
1986 27
1987 31
1988 24
1989 32
1990 43
1991 38
1992 33
1993 34
1994 47
1995 56
1996 44
1997 45
1998 58
1999 72
2000 87
2001 82
2002 102
2003 122
2004 159
2005 130
2006 160
2007 211
2008 233
2009 241
2010 256
2011 278
2012 331
2013 355
2014 301
2015 309
2016 306
2017 326
2018 359
2019 355
2020 379
2021 439
2022 412
2023 362
2024 298

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6,562 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials.
Heier JS, Khanani AM, Quezada Ruiz C, Basu K, Ferrone PJ, Brittain C, Figueroa MS, Lin H, Holz FG, Patel V, Lai TYY, Silverman D, Regillo C, Swaminathan B, Viola F, Cheung CMG, Wong TY; TENAYA and LUCERNE Investigators. Heier JS, et al. Among authors: wong ty. Lancet. 2022 Feb 19;399(10326):729-740. doi: 10.1016/S0140-6736(22)00010-1. Epub 2022 Jan 24. Lancet. 2022. PMID: 35085502 Clinical Trial.
Faricimab Treat-and-Extend for Diabetic Macular Edema: Two-Year Results from the Randomized Phase 3 YOSEMITE and RHINE Trials.
Wong TY, Haskova Z, Asik K, Baumal CR, Csaky KG, Eter N, Ives JA, Jaffe GJ, Korobelnik JF, Lin H, Murata T, Ruamviboonsuk P, Schlottmann PG, Seres AI, Silverman D, Sun X, Tang Y, Wells JA, Yoon YH, Wykoff CC; YOSEMITE and RHINE Investigators. Wong TY, et al. Ophthalmology. 2024 Jun;131(6):708-723. doi: 10.1016/j.ophtha.2023.12.026. Epub 2023 Dec 28. Ophthalmology. 2024. PMID: 38158159 Free article. Clinical Trial.
mRNA vaccine quality analysis using RNA sequencing.
Gunter HM, Idrisoglu S, Singh S, Han DJ, Ariens E, Peters JR, Wong T, Cheetham SW, Xu J, Rai SK, Feldman R, Herbert A, Marcellin E, Tropee R, Munro T, Mercer TR. Gunter HM, et al. Among authors: wong t. Nat Commun. 2023 Sep 21;14(1):5663. doi: 10.1038/s41467-023-41354-y. Nat Commun. 2023. PMID: 37735471 Free PMC article.
Intravitreal aflibercept 8 mg in neovascular age-related macular degeneration (PULSAR): 48-week results from a randomised, double-masked, non-inferiority, phase 3 trial.
Lanzetta P, Korobelnik JF, Heier JS, Leal S, Holz FG, Clark WL, Eichenbaum D, Iida T, Xiaodong S, Berliner AJ, Schulze A, Schmelter T, Schmidt-Ott U, Zhang X, Vitti R, Chu KW, Reed K, Rao R, Bhore R, Cheng Y, Sun W, Hirshberg B, Yancopoulos GD, Wong TY; PULSAR Investigators. Lanzetta P, et al. Among authors: wong ty. Lancet. 2024 Mar 23;403(10432):1141-1152. doi: 10.1016/S0140-6736(24)00063-1. Epub 2024 Mar 7. Lancet. 2024. PMID: 38461841 Clinical Trial.
Evaluation of Mavacamten in Symptomatic Patients With Nonobstructive Hypertrophic Cardiomyopathy.
Ho CY, Mealiffe ME, Bach RG, Bhattacharya M, Choudhury L, Edelberg JM, Hegde SM, Jacoby D, Lakdawala NK, Lester SJ, Ma Y, Marian AJ, Nagueh SF, Owens A, Rader F, Saberi S, Sehnert AJ, Sherrid MV, Solomon SD, Wang A, Wever-Pinzon O, Wong TC, Heitner SB. Ho CY, et al. Among authors: wong tc. J Am Coll Cardiol. 2020 Jun 2;75(21):2649-2660. doi: 10.1016/j.jacc.2020.03.064. J Am Coll Cardiol. 2020. PMID: 32466879 Free article. Clinical Trial.
Reply.
Lee VHF, Wong TCL. Lee VHF, et al. Among authors: wong tcl. Hepatology. 2022 May;75(5):1346. doi: 10.1002/hep.32379. Epub 2022 Feb 17. Hepatology. 2022. PMID: 35106779 No abstract available.
A polygenic risk score improves risk stratification of coronary artery disease: a large-scale prospective Chinese cohort study.
Lu X, Liu Z, Cui Q, Liu F, Li J, Niu X, Shen C, Hu D, Huang K, Chen J, Xing X, Zhao Y, Lu F, Liu X, Cao J, Chen S, Ma H, Yu L, Wu X, Wu X, Li Y, Zhang H, Mo X, Zhao L, Huang J, Wang L, Wen W, Shu XO, Takeuchi F, Koh WP, Tai ES, Cheng CY, Wong TY, Chang X, Chan MY, Gao W, Zheng H, Chen K, Chen J, He J, Tang CS, Lam KSL, Tse HF, Cheung CYY, Takahashi A, Kubo M, Kato N, Terao C, Kamatani Y, Sham PC, Heng CK, Hu Z, Chen YE, Wu T, Shen H, Willer CJ, Gu D. Lu X, et al. Among authors: wong ty. Eur Heart J. 2022 May 7;43(18):1702-1711. doi: 10.1093/eurheartj/ehac093. Eur Heart J. 2022. PMID: 35195259 Free PMC article.
Large language models for diabetes care: Potentials and prospects.
Sheng B, Guan Z, Lim LL, Jiang Z, Mathioudakis N, Li J, Liu R, Bao Y, Bee YM, Wang YX, Zheng Y, Tan GSW, Ji H, Car J, Wang H, Klonoff DC, Li H, Tham YC, Wong TY, Jia W. Sheng B, et al. Among authors: wong ty. Sci Bull (Beijing). 2024 Mar 15;69(5):583-588. doi: 10.1016/j.scib.2024.01.004. Epub 2024 Jan 4. Sci Bull (Beijing). 2024. PMID: 38220476 Free article. No abstract available.
6,562 results